Lv7
3810 积分 2024-12-03 加入
维布妥昔单抗联合化疗治疗儿童难治及复发霍奇金淋巴瘤10例分析
13小时前
已完结
PD-1 blockade for relapsed lymphoma post–allogeneic hematopoietic cell transplant: high response rate but frequent GVHD
18小时前
已完结
Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma
18小时前
已完结
Nivolumab for Relapsed/Refractory Classic Hodgkin Lymphoma After Failure of Autologous Hematopoietic Cell Transplantation: Extended Follow-Up of the Multicohort Single-Arm Phase II CheckMate 205 Trial
18小时前
已完结
Evidence-Based Minireview: What is the optimal timing of anti–PD-1 antibodies in relapsed classical Hodgkin lymphoma?
18小时前
已完结
Safety and efficacy of allogeneic hematopoietic stem cell transplant after PD-1 blockade in relapsed/refractory lymphoma
19小时前
已完结
PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation
19小时前
已完结
Multicenter phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma
19小时前
已完结
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin’s Lymphoma
6天前
已完结
Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation
6天前
已关闭
皖公网安备34019202002308
